Reduced functional brain activity response in cognitively intact apolipoprotein E ε4 carriers

The apolipoprotein E epsilon4 (APOE epsilon4) is the main known genetic risk factor for Alzheimer's disease. Genetic assessments in combination with other diagnostic tools, such as neuroimaging, ha ...

[1]  E. Tulving,et al.  Novelty encoding networks in the human brain: positron emission tomography data. , 1994, Neuroreport.

[2]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[3]  R. Dolan,et al.  Dissociating prefrontal and hippocampal function in episodic memory encoding , 1997, Nature.

[4]  R. Cowburn,et al.  Apolipoprotein E: a major piece in the Alzheimer's disease puzzle , 2001, Journal of Cellular and Molecular Medicine.

[5]  Nick C Fox,et al.  Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.

[6]  L. Nyberg,et al.  The betula prospective cohort study: Memory, health, and aging , 1997 .

[7]  Terry M. Peters,et al.  3D statistical neuroanatomical models from 305 MRI volumes , 1993, 1993 IEEE Conference Record Nuclear Science Symposium and Medical Imaging Conference.

[8]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[9]  Laura Fratiglioni,et al.  Worldwide Prevalence and Incidence of Dementia , 1999, Drugs & aging.

[10]  M. Egan,et al.  Brain-Derived Neurotrophic Factor val66met Polymorphism Affects Human Memory-Related Hippocampal Activity and Predicts Memory Performance , 2003, The Journal of Neuroscience.

[11]  Daniel R Weinberger,et al.  Imaging genomics. , 2003, British medical bulletin.

[12]  E Tulving,et al.  Priming and human memory systems. , 1990, Science.

[13]  A. Hofman,et al.  Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[14]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[15]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J L Andersson,et al.  Brain regions associated with episodic retrieval in normal aging and Alzheimer’s disease , 1999, Neurology.

[17]  Lars Nyberg,et al.  Altered Prefrontal Brain Activity in Persons at Risk for Alzheimer's Disease: An fMRI Study , 2003, International Psychogeriatrics.

[18]  G. Alexander,et al.  Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease , 1998, Neurology.

[19]  H. Soininen,et al.  Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ϵ4 allele , 1995, Neurology.

[20]  F. Lalonde,et al.  Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women , 2001, Neurology.

[21]  S. Heckers,et al.  Impaired hippocampal function during the detection of novel words in schizophrenia , 2004, Biological Psychiatry.

[22]  K. Kiehl,et al.  Neural pathways involved in the processing of concrete and abstract words , 1999, Human brain mapping.

[23]  J. Gee,et al.  Neural basis for semantic memory difficulty in Alzheimer's disease: an fMRI study. , 2003, Brain : a journal of neurology.

[24]  J. Mazziotta,et al.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Alexander,et al.  Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism , 2005 .

[26]  Charles D. Smith,et al.  Women at risk for AD show increased parietal activation during a fluency task , 2002, Neurology.

[27]  M. Sano.  Current Concepts in the Prevention of Alzheimer's Disease , 2003, CNS Spectrums.

[28]  J. Morris,et al.  Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.

[29]  D. Schacter,et al.  Task-specific repetition priming in left inferior prefrontal cortex. , 2000, Cerebral cortex.

[30]  M. Grossman,et al.  A Rule-Based Categorization Deficit in Alzheimer's Disease? , 2001, Brain and Cognition.

[31]  Margaret A. Pericak-Vance,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease , 1997 .

[32]  J. Winn,et al.  Brain , 1878, The Lancet.

[33]  C. Newton,et al.  Analysis of apolipoprotein E genotypes by the Amplification Refractory Mutation System. , 1991, Clinical chemistry.

[34]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  K Herholz,et al.  Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. , 1994, Dementia.

[36]  D. Salmon,et al.  The deterioration of semantic networks in patients with Alzheimer's disease: A cross-sectional study , 1997, Neuropsychologia.

[37]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[38]  H. Soininen,et al.  Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes , 1995, Neuroscience.

[39]  G. Siest,et al.  Apolipoprotein E-epsilon 4 allele and Alzheimer's disease. , 1993, Lancet.

[40]  Nick C Fox,et al.  Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Peter A. Bandettini,et al.  Detection versus Estimation in Event-Related fMRI: Choosing the Optimal Stimulus Timing , 2002, NeuroImage.

[42]  Norbert Schuff,et al.  Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia. , 2003, Archives of neurology.

[43]  L. Thal,et al.  Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs. , 1998, Journal of neural transmission. Supplementum.

[44]  D. Knopman,et al.  Dissociation of regional activation in mild AD during visual encoding , 2001, Neurology.

[45]  David P. Salmon,et al.  Dimensionality and clustering in the semantic network of patients with Alzheimer's disease. , 1993 .

[46]  A Hofman,et al.  Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes , 2002, Neurology.

[47]  Kewei Chen,et al.  Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  K Lehnertz,et al.  Verbal novelty detection within the human hippocampus proper. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[50]  H Yonezawa,et al.  Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. , 1997, Neuroscience letters.

[51]  H. Braak,et al.  Diagnostic Criteria for Neuropathologic Assessment of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[52]  J. Haxby,et al.  Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia , 1993, Neurobiology of Aging.

[53]  G. Alexander,et al.  Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. , 2002, The American journal of psychiatry.

[54]  Edward E. Smith,et al.  The Neural Basis for Categorization in Semantic Memory , 2002, NeuroImage.

[55]  Karl J. Friston,et al.  Analysis of fMRI Time-Series Revisited , 1995, NeuroImage.

[56]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[57]  T Jones,et al.  Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. , 1981, Brain : a journal of neurology.

[58]  J. Desmond,et al.  Prefrontal cortex and recognition memory. Functional-MRI evidence for context-dependent retrieval processes. , 1998, Brain : a journal of neurology.

[59]  M J de Leon,et al.  Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. , 1992, Archives of neurology.

[60]  A. Saykin,et al.  Functional differentiation of medial temporal and frontal regions involved in processing novel and familiar words: an fMRI study. , 1999, Brain : a journal of neurology.

[61]  G. Small,et al.  Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[62]  G W Small.  Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease. , 1996, The Journal of clinical psychiatry.

[63]  J C Mazziotta,et al.  Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. , 1995, JAMA.

[64]  Jemett L. Desmond,et al.  Semantic encoding and retrieval in the left inferior prefrontal cortex: a functional MRI study of task difficulty and process specificity , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[65]  A. King,et al.  The question of familial meningiomas and schwannomas: , 2000, Neurology.

[66]  Charles D. Smith,et al.  Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. , 1999, Neurology.

[67]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[68]  Akira Homma,et al.  Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E ϵ4 allele , 1997, Neuroscience Letters.

[69]  Hans-Jochen Heinze,et al.  Human Hippocampal and Parahippocampal Activity during Visual Associative Recognition Memory for Spatial and Nonspatial Stimulus Configurations , 2003, The Journal of Neuroscience.

[70]  A. Hofman,et al.  Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.